Completed PHASE4 INTERVENTIONAL 2-arm
NCT06718062
Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia
Sponsor: Hansung University
Conditions
Hypertension,Essential Hyperuricemia
Updated 1 time since 2025 Last updated: Dec 4, 2024 Started: May 1, 2021 Primary completion: May 1, 2024 Completion: Oct 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Hypertension,Essential and Hyperuricemia and is currently completed. Hansung University leads this study, which shows 1 recorded version since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
1 version recorded Completed — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Hansung University
Data source: Hansung University
For direct contact, visit the study record on ClinicalTrials.gov .